Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 29, 2006
Efficacy and safety of inhaled fluticasone propionate chlorofluorocarbon in 2- to 4-year-old patients with asthma: results of a double-blind, placebo-controlled studyRichard L Wasserman, James W Baker, Kenneth T Kim, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2002
Efficacy and safety of fluticasone propionate 250 microg administered once daily in patients with persistent asthma treated with or without inhaled corticosteroidsWilliam E Berger, Linda B Ford, Todd Mahr, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trialCourtney Crim, Sally Stone, Valerie Millar, et al.The Journal of Pediatrics|November 11, 2006
Efficacy and safety of fluticasone propionate hydrofluoroalkane inhalation aerosol in pre-school-age children with asthma: a randomized, double-blind, placebo-controlled studyPaul Y Qaqundah, Robert W Sugerman, Elaina Ceruti, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 31, 2006
Fluticasone propionate hydrofluoroalkane inhalation aerosol in patients receiving inhaled corticosteroidsWilliam R Lumry, Michael M Conway, Craig F LaForce, et al.Health and Quality of Life Outcomes|November 16, 2013
Item selection, reliability and validity of the Shortness of Breath with Daily Activities (SOBDA) questionnaire: a new outcome measure for evaluating dyspnea in chronic obstructive pulmonary diseaseTeresa K Wilcox, Wen-Hung Chen, Kellee A Howard, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 9, 2017
A randomized trial of once-daily fluticasone furoate/vilanterol or vilanterol versus placebo to determine effects on arterial stiffness in COPDSurya P Bhatt, Mark T Dransfield, John R Cockcroft, et al.Lancet (London, England)|May 21, 2016
Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trialJørgen Vestbo, Julie A Anderson, Robert D Brook, et al.Journal of the National Medical Association|February 21, 2002
Tobacco control: consensus report of the National Medical AssociationSharon Marable, Courtney Crim, Gary C Dennis, et al.The European Respiratory Journal|September 29, 2012
The Study to Understand Mortality and Morbidity in COPD (SUMMIT) study protocolJørgen Vestbo, Julie Anderson, Robert D Brook, et al.Pageof 9